Navigation Links
Ten years later, Dolly is still making headlines

The lead researcher for the team who - 10 years ago - created the cloned sheep "Dolly," will kick off the 2006 American Association of Pharmaceutical Scientists' (AAPS) National Biotechnology Conference in Boston, June 18-21. At the meeting, nearly two-thousand of the world's leading scientists will discuss a variety of critical issues affecting pharmaceutical biotechnology including Biogenerics, a field that is being hailed as the next revolution in healthcare.

"At AAPS, we are committed to tackling the latest issues ?even the toughest issues ?and exposing our members to disparate points of view so they ?as the most highly trained scientists in the world ?can draw their own conclusions," said John Lisack, AAPS executive director. "With topics like cloning and biogenerics headlining this year's event, there is no more exciting and challenging time to be in the field of pharmaceutical sciences than now."

The following topics will headline this year's meeting:

Creator of "Dolly" and world-renowned scientists share insight

Making his first U.S. appearance since his book, About Dolly, hit shelves earlier this month, Dr. Ian Wilmut, the lead researcher of a team of scientists who were first to successfully clone an animal, Dolly the sheep, ten years ago, will speak about his plans to clone embryos to alter disease genes in humans. Wilmut will be joined by two other leaders in biotechnology research, Dr. Kevin Eggan of the Harvard Stem Cell Institute, where plans were just announced to create the world's first cloned human embryonic stem cells, and Dr. Burt Adelman of Biogen Idec, the company that produces the recently re-approved multiple sclerosis drug, Tysabri. The Plenary Session is Monday, June 19 from 8:30 a.m. to 11:30 a.m. at the Hynes Convention Center.

Biogenerics ?The next revolution in health care?

Generic biopharmaceutical drugs, or biogenerics, are widely available in Europe and Australia, but the first biogeneric was just approved last month in the United States by the Food and Drug Administration (FDA). This approval has opened a pandora's box of issues. Biopharmaceutical medications are some of the most expensive medicines on the market. Approving generic formulas, therefore, has the potential to put once inaccessible drugs within the reach of millions more people, but at what cost? At the Boston meeting, there will be an Open Forum on Sunday, June 18 from 8 a.m. to 5:15 p.m. in the Hynes Convention Center to discuss the various regulatory, scientific and ethical issues surrounding generic biopharmaceuticals, as well as:

  • Why is the FDA slow to approve biogenerics?
  • What are the risks of a biogeneric drug, like a human growth hormone, being used for the off-label purpose of anti-aging?
  • With $20B of biotechnology-derived product losing patent protection over the next few years, how will the FDA handle this influx of legal and regulatory challenges?

National Biotechnology Conference

The AAPS National Biotechnology Conference is an annual event incorporating all aspects of pharmaceutical biotechnology and providing an open forum for discussion of industry topics. The conference will take place June 18?1 at the John B. Hynes Convention Center, Boston, Mass.


'"/>

Source:American Association of Pharmaceutical Scientists


Related biology news :

1. Artifical cornea lets woman blind 20 years see
2. Retrovirus struck ancestors of chimpanzees and gorillas millions of years ago, but did not affect ancestral humans
3. Hunger in America rises by 43 percent over last five years
4. Picky female frogs drive evolution of new species in less than 8,000 years
5. Bone marrow stem cells may heal hearts even years after heart attacks
6. Carbon cycle was already disrupted millions of years ago
7. Ancient ants arose 140-168 million years ago
8. Bt cotton in China fails to reap profit after seven years
9. UCLA scientists strengthen case for life more than 3.8 billion years ago
10. Allergy battle could be won in five years, says scientist
11. Scientists describe new African monkey genus ?first in 83 years
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/2/2016)... NEW YORK , June 2, 2016   The ... (Weather), is announcing Watson Ads, an industry-first capability in which ... advertising, by being able to ask questions via voice or ... Marketers have long ... with the consumer, that can be personal, relevant and valuable; ...
(Date:5/24/2016)... IRVINE, Calif. , May 24, 2016 Ampronix facilitates superior patient care ... LMD3251MT  3D medical LCD display is the latest premium product recently added to ... ... ... Sony 3d Imaging- LCD Medical Display- Ampronix News ...
(Date:5/12/2016)... , May 12, 2016 WearablesResearch.com ... just published the overview results from the Q1 wave ... the recent wave was consumers, receptivity to a program ... data with a health insurance company. "We ... to share," says Michael LaColla , CEO of ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... , June 23, 2016  Blueprint Bio, a company ... to the medical community, has closed its Series A ... Nunez . "We have received a commitment ... capital we need to meet our current goals," stated ... us the runway to complete validation on the current ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... at the Pennsylvania Convention Center and will showcase its product’s latest features from ... also be presenting a scientific poster on Disrupting Clinical Trials in The Cloud ...
(Date:6/23/2016)... , June 22, 2016  Amgen (NASDAQ: ... the QB3@953 life sciences incubator to accelerate ... The shared laboratory space at QB3@953 was created to ... key obstacle for many early stage organizations - access ... the sponsorship, Amgen launched two "Amgen Golden Ticket" awards, ...
(Date:6/22/2016)... , June 22, 2016 Research and ... Global Markets" report to their offering. ... billion in 2014 from $29.3 billion in 2013. The market is ... of 13.8% from 2015 to 2020, increasing from $50.6 billion in ... projected product forecasts during the forecast period (2015 to 2020) are ...
Breaking Biology Technology: